Outstanding challenges for rotavirus vaccine introduction in low-income countries - a systematic review

Danish Medical Bulletin

Volumn 58, Issue 10, 2011, Pages 8-

  Ustrup, Marte ^a   Madsen, Lizell B ^a   Bygbjerg, Ib C ^a   Konradsen, Flemming ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD HEALTH; DIARRHEA; DRUG EFFICACY; HUMAN; IMMUNIZATION; INTUSSUSCEPTION; IRRITABILITY; OTITIS MEDIA; RHINOPHARYNGITIS; ROTAVIRUS INFECTION; SIDE EFFECT; SYSTEMATIC REVIEW; VOMITING;

EID: 80053611042     PISSN: None     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Black RE, Cousens S, Johnson HL et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375:1969-87.
2. Parashar UD, Burton A, Lanata C et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009;200 Suppl 1:S9-S15.
3. Parashar UD, Hummelman EG, Bresee JS et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
4. World Health Organization, PATH, GAVI Alliance. WHO recommends global use of rotavirus vaccines. Geneva and Seattle: World Health Organization, PATH, GAVI Alliance, 2009:1-3.
5. Chandran A, Fitzwater S, Zhen A et al. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics 2010;4:213-29.
6. de Zoysa I, Feachem RG. Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull World Health Organ 1985;63:569-83.
7. Desselberger U, Manktelow E, Li W et al. Rotaviruses and rotavirus vaccines. Br Med Bull 2009;90:37-51.
8. Patel MM, Steele D, Gentsch JR et al. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011;30:S1-S5.
9. Advisory Committee on Immunization Practices. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1-20.
10. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999;48:1007.
11. European Medicines Agency. Background information on the procedure. 2006. www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_before-authorisation/human/000639/WC500054590.pdf (16 July, 2011).
12. United States Food and Drug Administration. FDA approves new vaccine to prevent rotavirus gastroenteritis in infants. 2006. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108588.htm (16 July, 2011).
13. GlaxoSmithKline. Summary of product characteristics. 2011. www.medicines.org.uk/EMC/medicine/17840/SPC/Rotarix/ (2 June, 2011).
14. Merck & Co. I. Full prescribing information. 2011. www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf (2 June, 2011).
15. Soares-Weiser K, Maclehose H, Ben-Aharon I et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2010;(5). Art. no.: CD008521. DOI: 10.1002/14651858.CD008521.
16. Buttery JP, Danchin MH, Lee KJ et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the national immunization program in Australia. Vaccine 2011;29:3061-6.
17. World Health Organization. Safety of rotavirus vaccines: postmarketing surveillance in the WHO region of the Americas. Wkly Epidemiol Rec 2011;86:66-72.
18. Patel NC, Hertel PM, Estes MK et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med 2010;362:314-9.
19. Armah GE, Sow SO, Breiman RF et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebocontrolled trial. Lancet 2010;376:606-14.
20. Steele AD, Madhi SA, Louw CE et al. Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa. Pediatr Infect Dis J 2011;30:125-30.
21. Fischer Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health 2011;11 Suppl 3:S16.
22. World Health Organization. Countries using rotavirus vaccine in national immunization schedule in 2009 and planned in 2010. 2011. www.who.int/nuvi/rotavirus/Countries_Using_RotaV_Nat_Immunization_Schedule-2009_planned-2010.pdf (25 January, 2011).
23. Bharat Biotech International Limited, Ministry of Science and Technology. A phase III clinical trial to evaluate the protective efficacy of three doses of oral rotavirus vaccine (ORV) 116E (ROTAVAC). 2011. http://clinicaltrials.gov/ct2/show/NCT01305109 (29 June, 2011).
24. International Medica Foundation. RotaShield: an oral rotavirus vaccine. 2011. www.intl-medica.org/rotashield.asp (29 June, 2011).
25. United Nations Children's Fund. Vaccine price data. 2011. www.unicef.org/supply/index_57476.html (11 July, 2011).
26. World Bank. Data: low income. 2009. http://data.worldbank.org/income-level/LIC (7 July, 2011).
27. PATH. Accelerating the introduction of rotavirus vaccines into GAVI-eligible countries. Seattle: PATH 2006:1-35.
28. World Health Organization. Immunization service delivery and accelerated disease control: vaccine volume calculator 2009. 2009. www.who.int/immunization_delivery/systems_policy/logistics/en/index4.html (10 August, 2011).
29. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15:29-56.
30. Dennehy PH, Brady RC, Halperin SA et al. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005;24:481-8.
31. Linhares AC, Carmo KB, Oliveira KK et al. Nutritional status in relation to the efficacy of the rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) in infants from Belem, para state, Brazil. Rev Inst Med Trop Sao Paulo 2002;44:13-6.
32. Cunliffe NA, Kilgore PE, Bresee JS et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ 1998;76:525-37.
33. Patel M, Shane AL, Parashar UD et al. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009;200 Suppl 1: S39-S48.
34. Ciarlet M, Sani-Grosso R, Yuan G et al. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Pediatr Infect Dis J 2008;27:874-80.
35. Simpson E, Wittet S, Bonilla J et al. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries. BMC Public Health 2007;7:281.
36. Mills A, Rasheed F, Tollman S. Strengthening health systems. In: Jamison DT, Breman JG, Measham AR et al, ed. Disease control priorities in developing countries. Washington: World Bank, 2006:87-102.
37. Simkhada B, Teijlingen ER, Porter M et al. Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs 2008;61:244-60.
38. Clark A, Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009;373:1543-9.
39. Patel MM, Clark AD, Glass RI et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009;27:2916-22.
40. Danchin MH, Bines JE. Defeating rotavirus? The global recommendation for rotavirus vaccination. N Engl J Med 2009;361:1919-21.